BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36221376)

  • 1. Prognostic significance of CD56 antigen in newly diagnosed multiple myeloma: A real-world retrospective study.
    Li L; Li X; Shang A; Zhao Y; Jin L; Zhao M; Shen W
    Medicine (Baltimore); 2022 Oct; 101(40):e30988. PubMed ID: 36221376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic Value of CD56 Expression in Newly Diagnosed Multiple Myeloma Patients and Its Related Factors].
    Wang XX; Zhang LL; Wang T; Hou JX; Wang ZT; Qin H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):777-782. PubMed ID: 37356939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of CD56 and CD19 in Patients with Newly Diagnosed Multiple Myeloma and Their Relationship with Karyotypes and Prognosis].
    Qiu Q; Zhu P; Wang MJ; Lu XZ; Dong YJ; Sun YH; Wang LH; Zhang Y; Bu DF; Wang WS; Liang ZY; Liu W; Qiu ZX; Ou JP; Cen XN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Aug; 24(4):1071-8. PubMed ID: 27531777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The prognostic relationship between CD56 expression and newly diagnosed multiple myeloma].
    Geng CY; Yang GZ; Wang HJ; Zhou HX; Zhang ZY; Jian Y; Chen WM
    Zhonghua Nei Ke Za Zhi; 2022 Feb; 61(2):164-171. PubMed ID: 35090251
    [No Abstract]   [Full Text] [Related]  

  • 5. Achieving minimal residual disease-negative by multiparameter flow cytometry may ameliorate a poor prognosis in MM patients with high-risk cytogenetics: a retrospective single-center analysis.
    Li H; Li F; Zhou X; Mei J; Song P; An Z; Zhao Q; Guo X; Wang X; Zhai Y
    Ann Hematol; 2019 May; 98(5):1185-1195. PubMed ID: 30721336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of hyperdiploidy in multiple myeloma patients with high-risk cytogenetics: a pilot study in China.
    Mei J; Zhai Y; Li H; Li F; Zhou X; Song P; Zhao Q; Yu Y; An Z; Wang L
    J Cancer Res Clin Oncol; 2018 Nov; 144(11):2263-2273. PubMed ID: 30167888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD56 Expression Is an Important Prognostic Factor in Multiple Myeloma Even with Bortezomib Induction.
    Skerget M; Skopec B; Zadnik V; Zontar D; Podgornik H; Rebersek K; Furlan T; Cernelc P
    Acta Haematol; 2018; 139(4):228-234. PubMed ID: 29920491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of CD56 expression in patients with multiple myeloma: a meta-analysis.
    Zhang L; Huang Y; Lin Y; Zhang A; Zou R; Xu H; Wang S
    Hematology; 2022 Dec; 27(1):122-131. PubMed ID: 35068378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Red Blood Cell Distribution Width to Platelet Ratio is an Independent Poor Prognostic Factor in Patients with Newly Diagnosed Multiple Myeloma.
    Li M; Bai Y; Sun X; Wang H; Li W; Xiao X; Chen Y; Sun K
    Discov Med; 2023 Apr; 35(175):157-167. PubMed ID: 37105925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic relevance of CD56 expression in multiple myeloma: a study including 107 cases treated with high-dose melphalan-based chemotherapy and autologous stem cell transplant.
    Chang H; Samiee S; Yi QL
    Leuk Lymphoma; 2006 Jan; 47(1):43-7. PubMed ID: 16321826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and prognostic values of 1p32.3 deletion detected through fluorescence in situ hybridization in patients with newly diagnosed multiple myeloma: a single-center study in China.
    Wang H; Meng H; Wang J; Lou Y; Zhou Y; Lin P; Li F; Liu L; Xu H; Yang M; Jin J
    Front Med; 2020 Jun; 14(3):327-334. PubMed ID: 31784918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newly diagnosed multiple myeloma patients with CD56 expression benefit more from autologous stem cell transplantation.
    Geng C; Zhou H; Wang H; Li Y; Leng Y; Zhang Z; Jian Y; Yang G; Chen W
    BMC Cancer; 2022 Dec; 22(1):1349. PubMed ID: 36564753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual Negativity of CD56 and CD117 Links to Unfavorable Cytogenetic Abnormalities and Predicts Poor Prognosis in Multiple Myeloma.
    Zheng D; Zhu M; Li Q; Wan W; Chen Y; Jing H
    J Clin Med; 2022 Nov; 11(21):. PubMed ID: 36362752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD56 expression in multiple myeloma: Correlation with poor prognostic markers but no effect on outcome.
    Koumpis E; Tassi I; Malea T; Papathanasiou K; Papakonstantinou I; Serpanou A; Tsolas E; Kapsali E; Vassilakopoulos TP; Papoudou-Bai A; Hatzimichael E
    Pathol Res Pract; 2021 Sep; 225():153567. PubMed ID: 34352440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of minimal residual disease detection by multiparameter flow cytometry in newly diagnosed multiple myeloma: an analysis of 106 patients].
    Deng SH; Xu Y; Sui WW; Wang HJ; Li ZJ; Wang TY; Liu W; Huang WY; Lyu R; Li J; Fu MW; Zou DH; An G; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2018 May; 39(5):376-381. PubMed ID: 29779345
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical characteristics and prognosis of patients with newly-diagnosed multiple myeloma with t(11;14)].
    Wang Y; Liu YF; Tao Y; Jin SW; Mi JQ
    Zhonghua Yi Xue Za Zhi; 2022 Sep; 102(36):2868-2873. PubMed ID: 36153872
    [No Abstract]   [Full Text] [Related]  

  • 17. [Analysis of the clinical effects and outcome of patients with double-hit high-risk multiple myeloma].
    Liu S; Shang J; Lin Y; Wang ZH; Wei TN; Lin L; Yang T; Chen WM
    Zhonghua Zhong Liu Za Zhi; 2021 Nov; 43(11):1209-1214. PubMed ID: 34794226
    [No Abstract]   [Full Text] [Related]  

  • 18. Absence of both CD56 and CD117 expression on malignant plasma cells is related with a poor prognosis in patients with newly diagnosed multiple myeloma.
    Pan Y; Wang H; Tao Q; Zhang C; Yang D; Qin H; Xiong S; Tao L; Wu F; Zhang J; Zhai Z
    Leuk Res; 2016 Jan; 40():77-82. PubMed ID: 26597998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The prognostic significance of dynamic monitoring of minimal residual disease (MRD) status in patients with newly-diagnosed multiple myeloma].
    Yang PY; Liu MM; Fan HQ; Yang YP; Han W; Yu XY; Yue TT; Su KJ; Guo Q; Gao SJ; Jin FY
    Zhonghua Xue Ye Xue Za Zhi; 2019 Jul; 40(7):584-588. PubMed ID: 32397022
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prognostic Significance of CD27 and CD56 on Newly Diagnosed MM Patients Treated with Bortezomib].
    Zhang CX; Wang HT; Zhang GJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Jun; 29(3):827-831. PubMed ID: 34105479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.